Literature DB >> 24673465

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.

M Cicardi1, W Aberer, A Banerji, M Bas, J A Bernstein, K Bork, T Caballero, H Farkas, A Grumach, A P Kaplan, M A Riedl, M Triggiani, A Zanichelli, B Zuraw.   

Abstract

Angioedema is defined as localized and self-limiting edema of the subcutaneous and submucosal tissue, due to a temporary increase in vascular permeability caused by the release of vasoactive mediator(s). When angioedema recurs without significant wheals, the patient should be diagnosed to have angioedema as a distinct disease. In the absence of accepted classification, different types of angioedema are not uniquely identified. For this reason, the European Academy of Allergy and Clinical Immunology gave its patronage to a consensus conference aimed at classifying angioedema. Four types of acquired and three types of hereditary angioedema were identified as separate forms from the analysis of the literature and were presented in detail at the meeting. Here, we summarize the analysis of the data and the resulting classification of angioedema.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  angioedema; clinical immunology; dermatology; education; urticaria

Mesh:

Year:  2014        PMID: 24673465     DOI: 10.1111/all.12380

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  143 in total

1.  [Acquired angioedema with C1-INH deficiency and accompanying chronic spontaneous urticaria in a patient with chronic lymphatic B cell leukemia].

Authors:  N Klossowski; S A Braun; V von Gruben; C Losem; D Plewe; B Homey; S Meller
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

2.  Treatment of ACEI-related angioedema with icatibant: a case series.

Authors:  Maria Bova; Mar Guilarte; Anna Sala-Cunill; Paolo Borrelli; Grazia Maria Luisa Rizzelli; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

3.  Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.

Authors:  U C Steiner; M Keller; P Schmid; S Cichon; W A Wuillemin
Journal:  Clin Exp Immunol       Date:  2017-03-19       Impact factor: 4.330

4.  Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation.

Authors:  Pavla Hujová; Přemysl Souček; Lucie Grodecká; Hana Grombiříková; Barbora Ravčuková; Pavel Kuklínek; Roman Hakl; Jiří Litzman; Tomáš Freiberger
Journal:  J Clin Immunol       Date:  2020-01-25       Impact factor: 8.317

5.  Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.

Authors:  A Deroux; I Boccon-Gibod; O Fain; P Pralong; Y Ollivier; A Pagnier; K Djenouhat; A Du-Thanh; A Gompel; C Faisant; D Launay; L Bouillet
Journal:  Clin Exp Immunol       Date:  2016-09       Impact factor: 4.330

Review 6.  Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis.

Authors:  Asif Mehmood; Hafez Mohammad Ammar Abdullah; Faisal Inayat; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 7.  Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.

Authors:  Charles Faisant; Aurélie Du Thanh; Catherine Mansard; Alban Deroux; Isabelle Boccon-Gibod; Laurence Bouillet
Journal:  J Clin Immunol       Date:  2016-11-08       Impact factor: 8.317

Review 8.  Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Authors:  Henriette Farkas
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

Review 9.  [Drug-induced angioedema : Focus on bradykinin].

Authors:  B Sachs; T Meier; M M Nöthen; C Stieber; J Stingl
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

10.  A score for the differential diagnosis of bradykinin- and histamine-induced head and neck swellings.

Authors:  M Lenschow; M Bas; F Johnson; M Wirth; U Strassen
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.